The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
TAFI, or Plasma Procarboxypeptidase B, Couples the Coagulation and Fibrinolytic Cascades through the Thrombin-Thrombomodulin Complex
Open accessAbstract
TAFI (thrombin-activatable fibrinolysis inhibitor) is a recently discovered plasma protein that can be activated by thrombin-catalyzed proteolysis to a carboxypeptidase B-like enzyme that inhibits fibrinolysis. This work shows that the thrombin-thrombomodulin complex, rather than free thrombin, is the most likely physiologic activator. Thrombomodulin increases the catalytic efficiency of the reaction by a factor of 1250, an effect expressed almost exclusively through an increase in kcat. The kinetics of the reaction conform to a model whereby thrombin can interact with either TAFI (Km = 1.0 microM) or thrombomodulin (Kd = 8.6 nM), and either binary complex so formed can then interact with the third component to form the ternary thrombin-thrombomodulin-TAFI complex from which activated TAFI is produced with kcat = 1.2 s-1. This work also shows that activated TAFI down-regulates tPA-induced fibrinolysis half-maximally at a concentration of 1.0 nM in a system of purified components. This concentration of TAFI is about 2% of the level of the zymogen in plasma, which indicates that ample activated TAFI could be generated to very significantly modulate fibrinolysis in vivo. Therefore, TAFI in vitro and possibly in vivo defines an explicit molecular connection between the coagulation and fibrinolytic cascades, such that expression of activity in the former down-regulates the activity of the latter.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neville, D. M. (1971) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61792-2 · Cited by 1,989
Basic and clinical aspects of fibrinolysis and thrombolysis
Collen, D., & Lijnen, H. (1991) · Blood · doi:10.1182/blood.v78.12.3114.3114 · Cited by 688
Purification and Characterization of TAFI, a Thrombin-activable Fibrinolysis Inhibitor
Bajzar, L., Manuel, R., & Nesheim, M. E. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.24.14477 · Cited by 680
Self-citationEaton, D. L., Malloy, B. E., Tsai, S. P., Henzel, W., & Drayna, D. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54713-x · Cited by 382
Esmon, C. T. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.10.7615164 · Cited by 377
Initial plasmin-degradation of fibrin as the basis of a positive feed-back mechanism in fibrinolysis
SUENSON, E., LUTZEN, O., & THORSEN, S. (1984) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1984.tb08132.x · Cited by 270
Glaser, C. B., Morser, J., Clarke, J. H., Blasko, E., McLean, K., Kuhn, I., Chang, R. J., Lin, J. H., Vilander, L., & Andrews, W. H. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116151 · Cited by 233
Self-citationBoskovic, D. S., Giles, A. R., & Nesheim, M. E. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)86975-7 · Cited by 98
Self-citationInitiation of the Protein C Pathway
Esmon, C. T., Johnson, A. E., & Esmon, N. L. (1991) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1991.tb43689.x · Cited by 30
Cited by
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
Cines, D. B., Pollak, E. S., Buck, C. A., Loscalzo, J., Zimmerman, G. A., McEver, R. P., Pober, J. S., Wick, T. M., Konkle, B. A., Schwartz, B. S., et al. (1998) · PubMed · doi:10.1182/blood.v91.10.3527 · Cited by 2,256
New Fundamentals in Hemostasis
Versteeg, H. H., Heemskerk, J. W. M., Levi, M., & Reitsma, P. H. (2013) · Physiological Reviews · doi:10.1152/physrev.00016.2011 · Cited by 1,126
The interactions between inflammation and coagulation
Esmon, C. T. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05753.x · Cited by 1,003
Levi, M., & van der Poll, T. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181c98d21 · Cited by 984
Bidirectional Relation Between Inflammation and Coagulation
Levi, M., van der Poll, T., & Büller, H. R. (2004) · Circulation · doi:10.1161/01.cir.0000131660.51520.9a · Cited by 941
Esmon, C. T. (2003) · Chest · doi:10.1378/chest.124.3_suppl.26s · Cited by 719
Endothelium—role in regulation of coagulation and inflammation
van Hinsbergh, V. W. M. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-011-0285-5 · Cited by 588
Polyphosphate modulates blood coagulation and fibrinolysis
Smith, S. A., Mutch, N. J., Baskar, D., Rohloff, P., Docampo, R., & Morrissey, J. H. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507195103 · Cited by 549
The complexity of neurobiological processes in acute ischemic stroke
Brouns, R., & De Deyn, P. P. (2009) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2009.04.001 · Cited by 526
The Dynamics of Thrombin Formation
Mann, K. G., Butenas, S., & Brummel, K. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000046238.23903.fc · Cited by 520
Interactions between coagulation and complement—their role in inflammation
Oikonomopoulou, K., Ricklin, D., Ward, P. A., & Lambris, J. D. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-011-0280-x · Cited by 486
Esmon, C. T. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00261.x · Cited by 442
The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Hirsh, J., Guyatt, G., Albers, G. W., & Schünemann, H. J. (2004) · Chest · doi:10.1378/chest.126.3_suppl.172s · Cited by 411
New insights into the molecular mechanisms of the fibrinolytic system
RIJKEN, D. C., & LIJNEN, H. R. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.03220.x · Cited by 382
Thrombin activatable fibrinolysis inhibitor and the risk for deep vein thrombosis
van Tilburg, N. H., Rosendaal, F. R., & Bertina, R. M. (2000) · Blood · doi:10.1182/blood.v95.9.2855.009k02_2855_2859 · Cited by 373
Meltzer, M. E., Lisman, T., de Groot, P. G., Meijers, J. C. M., le Cessie, S., Doggen, C. J. M., & Rosendaal, F. R. (2010) · Blood · doi:10.1182/blood-2010-02-267740 · Cited by 364
Signaling pathways and intervention therapies in sepsis
Zhang, Y.-Y., & Ning, B.-T. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00816-9 · Cited by 349
Di Cera, E. (2008) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2008.01.001 · Cited by 335
Two-Way Interactions Between Inflammation and Coagulation
Levi, M., & van der Poll, T. (2005) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2005.07.004 · Cited by 334
Pathophysiology and Treatment of Coagulopathy in Massive Hemorrhage and Hemodilution
Bolliger, D., Görlinger, K., Tanaka, K. A., & Warner, D. S. (2010) · Anesthesiology · doi:10.1097/aln.0b013e3181f22b5a · Cited by 325
Crosstalk between inflammation and thrombosis
Esmon, C. T. (2004) · Maturitas · doi:10.1016/j.maturitas.2003.10.015 · Cited by 325
Role of Na+and K+in Enzyme Function
Page, M. J., & Di Cera, E. (2006) · Physiological Reviews · doi:10.1152/physrev.00008.2006 · Cited by 312
Ophidian envenomation strategies and the role of purines
Aird, S. D. (2002) · Toxicon · doi:10.1016/s0041-0101(01)00232-x · Cited by 300
The endothelial cell protein C receptor aids in host defense against Escherichia coli sepsis
Taylor, F. B., Stearns-Kurosawa, D. J., Kurosawa, S., Ferrell, G., Chang, A. C. K., Laszik, Z., Kosanke, S., Peer, G., & Esmon, C. T. (2000) · Blood · doi:10.1182/blood.v95.5.1680.005k33_1680_1686 · Cited by 297
Regulation of blood coagulation
Esmon, C. T. (2000) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(99)00266-6 · Cited by 283
Lisman, T., Leebeek, F. W. G., Mosnier, L. O., Bouma, B. N., Meijers, J. C. M., Janssen, H. L. A., Nieuwenhuis, H. K., & De Groot, P. G. (2001) · Gastroenterology · doi:10.1053/gast.2001.25481 · Cited by 281
WANG, X., CHENG, Q., XU, L., FEUERSTEIN, G. Z., HSU, M., SMITH, P. L., SEIFFERT, D. A., SCHUMACHER, W. A., OGLETREE, M. L., & GAILANI, D. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01236.x · Cited by 278
Endothelial cell protein C receptor plays an important role in protein C activation in vivo
Taylor, F. B., Peer, G. T., Lockhart, M. S., Ferrell, G., & Esmon, C. T. (2001) · Blood · doi:10.1182/blood.v97.6.1685 · Cited by 265
Thrombin, Thrombomodulin and TAFI in the Molecular Link Between Coagulation and Fibrinolysis
Nesheim, M., Wang, W., Boffa, M., Nagashima, M., Morser, J., & Bajzar, L. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657557 · Cited by 258
Self-citationThachil, J., & Toh, C.-H. (2009) · Blood Reviews · doi:10.1016/j.blre.2009.04.002 · Cited by 177
“Regulation of fibrinolysis is mainly through plasminogen activator inhibitor (PAI)-1 and thrombin activatable fibrinolysis inhibitor (TAFI).(35) PAI-2 is also involved physiologically in pregnancy.”
BackgroundDIC: which laboratory tests are most useful
Levi, M., & Meijers, J. C. (2011) · Blood Reviews · doi:10.1016/j.blre.2010.09.002 · Cited by 146
Metadata
- Authors
- Bajzar, L., Morser, J., & Nesheim, M.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1996-07
- Volume
- 271
- Issue
- 28
- Pages
- 16603-16608
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2066822578
- Cited by
- 644
- References
- 9
- FWCI
- 8.17
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.